Companies / Odyssey Therapeutics

Odyssey Therapeutics

United States

Odyssey Therapeutics develops therapeutic candidates for autoimmune and inflammatory diseases

Odyssey Therapeutics, based in United States, has 11 investors on file, among them Activant Capital, Ascenta Capital and Catalio Capital Management. Its latest round on record is Series C+, 10 Sept 2025. Its site was last checked 12 Nov 2026: site answers.

odysseytx.com

Funding

1 round on record

Latest roundSeries C+10 Sept 2025

Since that round1 year 2 monthsno later round on record

Investors in its rounds72 with a VCinfo profile

Sept 2025Series C+Led by Affinity Asset Advisors, with Lightspeed Venture Partners, Jeito Capital and 4 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

SEC Form D filings

5 filings

$214M sold4 Dec 2025 $117M sold of $121M offered14 Aug 2024 $97.1M sold of $106M offered15 Dec 2023 $168M sold of $175M offered27 Oct 2022 $91.6M sold14 Oct 2021

Filed by Odyssey Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

11 investors on file

Investor	Evidence	Type
Activant Capital	Portfolio page	Venture capital
Ascenta Capital	Portfolio page	Venture capital
Catalio Capital Management	Portfolio page	Venture capital
Dimension	Portfolio page	Venture capital
Foresite Capital	Portfolio page	Venture capital
Global BioAccess Fund	Portfolio page	Venture capital
GreatPoint Ventures	Portfolio page	Venture capital
Jeito Capital	Page + round	Venture capital
Lightspeed Venture Partners	Page + round	Venture capital
Sanofi Ventures	Portfolio page	Corporate VC
SR One	Portfolio page	Venture capital

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

At a glance

Latest round: Series C+, 10 Sept 2025
Investors on file: 11
Founded: 2000
Employees: 51-200
Headquarters: United States
Open roles: 5
Site: Answers
Last checked: 12 Nov 2026

Company data by Fundup AI. Also from Wikidata.

Backed by the same investors

Companies sharing two or more investors with Odyssey Therapeutics.

Alveus Therapeutics3 shared

Enveda Biosciences3 shared

Korsana3 shared

Latigo3 shared

Abridge2 shared

Adarx2 shared

Get this company as JSON

GET /v1/companies/odysseytx.com
GET /v1/companies/odysseytx.com/investors
GET /v1/companies/odysseytx.com/news

API docs · Get a free key · Your API key

Raising a round?

See which investors fit your startup, ranked by what they actually back.

Check investor fit

Free account · no card

Get Odyssey Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Activant Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in

Your API key Read the docs

Ask AI5 plain-English investor searches a day
Full listsEvery portfolio row and two-firm overlap
API and MCP100 REST or MCP calls a month, one key
AlertsFollow 5 investors for portfolio and fund changes

VCinfo API

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/odysseytx.com/investors

# also
GET /v1/companies/odysseytx.com
GET /v1/companies/odysseytx.com/news

The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing